Skip to main content
. 2017 Apr 6;35(15):1695–1703. doi: 10.1200/JCO.2016.70.4072

Fig 4.

Fig 4.

Survival plots by biomarker levels: (A) central-review progression-free survival (PFS) by chromogranin A (CGA); (B) overall survival by CGA; (C) central-review PFS by neuron-specific enolase (NSE); (D) overall survival (OS) by NSE; (E) central-review PFS by 5-hydroxyindoleacetic acid (5HIAA); and (F) overall survival by 5HIAA. HR, hazard ratio; NR, not reported.